Germany: Interim findings from an early-stage study suggest that BioVAT, a tissue-engineered cardiac muscle patch therapy, may help remuscularize the heart in patients with advanced heart ...

Early report on modular BioVAT patches in advanced stage C or D disease ...

Researchers at the University Medical Center Göttingen (UMG) and the University Hospital of Schleswig-Holstein (UKSH) have ...

Repairon, a biotechnology company developing regenerative cardiac therapies, today announced that clinical results evaluating its engineered human heart muscle tissue for patients with advanced heart ...

Researchers at the University Medical Center Göttingen (UMG) and the University Hospital of Schleswig-Holstein (UKSH) have made a significant breakthrough in the treatment of severe heart failure: For ...

Researchers have developed a scalable bioreactor-based system to produce cardiac organoids that successfully integrated into ...

Myocardial infarction remains one of the leading causes of death worldwide. Following an infarction, part of the heart muscle ...

Duchenne Parent Project Spain has launched the BEAT Project to develop a three-dimensional heart-on-a-chip model that could help researchers to study cardiac fibrosis and assess potential ...

Researchers at the University of California, Irvine, have developed a polymeric biohybrid cardiac device that harnesses the power of light to electrically and mechanically control living heart tissue ...